Lobbying return by Janssen Sciences Ireland UC
HealthTo discuss the challenge of delayed patient access to new medicines and highlight the potential for the new IPHA Framework Agreement to improve access to innovation if implemented::To highlight the potential value of the national strategy for the life sciences and promote…